Industry Background:
Huge government spending in healthcare segment will help to boost global transcriptomics market in the forecasted period. Transcriptomics is the study of entire set of RNA transcripts produced by the genome of any organism. Upsurge in advancements in the field of transcriptomics including extensive use of RNA-sequencing. New innovations such as those pertaining to next-generation sequencing (NGS) and RNA interference (RNAi) have birthed as a result of the technological advancements in the international transcriptomics market. With enhanced precision and accuracy, these cutting-edge technologies can be put to use with a view to help researcher’s investigator the transcriptional activity of a vast range of diverse organisms.
According to AMA, the market for Transcriptomics is expected to register a CAGR of 13.2% during the forecast period to 2026. This growth is primarily driven by Increase in Advancements in the Field Of Transcriptomics Such As Extensive Use of RNA-Sequencing and Increase in Application of Transcriptomics, Which Includes Drug Discovery.
Globally, a noticeable market trend is evident Upsurge in Funding and Grants By Various Private and Government Organizations
. The Health Care Technology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as QIAGEN (Exiqon) (Germany), Thermo Fisher Scientific Inc. (United States), Illumina, Inc. (United States), Agilent Technologies (United States), GE Healthcare Dharmacon Inc. (United States), Bio-Rad Laboratories, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (United States), Fluidigm Corporation (United States) and Promega Corporation. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Market Drivers
- Increase in Advancements in the Field Of Transcriptomics Such As Extensive Use of RNA-Sequencing
- Increase in Application of Transcriptomics, Which Includes Drug Discovery
Market Trend
- Upsurge in Funding and Grants By Various Private and Government Organizations
- Growing Amount of Investments Directed Toward Research and Development Activities In Molecular Genetics
Restraints
- High Cost of Service
- Certain Drawbacks of RNA Sequencing
Opportunities
Increasing Government Spending In Emerging Countries
Challenges
Dearth of Trained Professionals
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Transcriptomics Study Sheds Light on
The Transcriptomics Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Transcriptomics industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Transcriptomics industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.